Intrinsiqs

Is Achieve Life Sciences, Inc. overvalued?

Achieve Life Sciences, Inc. (ACHV) — key valuation metrics and fundamentals.

No verdict
Price
$7.06
Fair value
Current P/E
Normal P/E
Market cap
$724.8M
Dividend yield
0.0%
Return on equity
-892.1%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ACHV's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 9 Sep 2026.